30.07.2021 22:32

Xoran Technologies sponsors clinical research at Providence Saint John's Health Center, Santa Monica, CA

Folgen
Werbung

ANN ARBOR, Mich., July 30, 2021 /PRNewswire/ -- Xoran Technologies announced today that the company has commenced a clinical trial at St. Johns-Providence to document a series of cases using Xoran's xCAT IQ mobile CT scanner.

Xoran xCAT IQ in use during neurosurgical clinical research. The study is designed to examine benefits associated with easily obtained CT imaging of the head at the point of care, instead of transporting the critical patient to a conventional scanner.

"... xCAT IQ used intraoperatively, advancing the field of medical imaging in support of complex neurosurgical cases."

The intent of the study is to demonstrate that the selected techniques and resulting image quality are adequate for clinical assessment of common neurosurgical conditions.

The study includes patients undergoing complex cranial neurosurgical procedures which can greatly benefit from low dose intraoperative imaging—allowing surgeons to view anatomy during surgery and confirming surgical completeness. These procedures can include endonasal pituitary and skull base tumor resection, and open craniotomy treatment of tumors such as meningioma, glioblastoma, or acoustic neuroma, ventricular shunts and/or neurosurgical procedures for hydrocephalus, deep brain stimulation electrodes, subdural hematoma evacuation, or ventricular endoscopy.

The study is designed to examine benefits associated with easily obtained CT imaging of the head at the point of care, instead of transporting the critical patient to a conventional scanner. Other points of interest include the ability to obtain intra-operative imaging prior to procedure completion, the potential for reduced radiation exposure, ease-of-use, and ease-of-access to imaging.

Principal investigators of the study include Chester Griffiths MD, FACS, Professor of Surgery and Garni Barkhoudarian MD, FAANS, Associate Professor of Neuroscience / Neurosurgery. Co-investigators are Daniel Kelly MD, Kian Karimi MD, and Nathan Pierce MD.

"We are very pleased to support doctors Griffiths and Barkhoudarian, and his colleagues—to see the xCAT IQ used intraoperatively, advancing the field of medical imaging in support of these complex neurosurgical cases," said Laura Dennis, Xoran's Vice-President of Sales and Marketing. "Xoran is committed to meeting the needs of today's surgeons, helping them provide real-time low dose imaging, in the OR and the critical care unit."

xCAT IQ is a mobile CT scanner which can be positioned in the operating room to acquire cranial images at the time of surgery. This device, which resembles a large cart, is relatively compact, can be pushed into position by a single operator. Once in place, acquisition of the CT scan takes about 40 seconds and image reconstruction takes a couple of minutes.

With a two-decade track record of innovation in medical CBCT imaging, Xoran understands the CT needs and practical considerations in both the OR and office settings.

About Xoran Technologies

Since 2001, Xoran is the pioneer and medical market leader in low-dose radiation, cone beam CT systems specifically designed for the patient's point-of-care. Providers around the world rely on our industry-leading MiniCAT™, xCAT™, VetCAT and vTRON systems to diagnose and treat patients. Xoran is based in Ann Arbor, Michigan. 

For more information visit www.xorantech.com/xCAT 
Pacific Neuroscience Institute www.PacificNeuro.org 

© 2021 Xoran Technologies, LLC

Xoran Technologies, LLC. We make the complex simple. (PRNewsfoto/Xoran Technologies, LLC)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/xoran-technologies-sponsors-clinical-research-at-providence-saint-johns-health-center-santa-monica-ca-301345454.html

SOURCE Xoran Technologies, LLC

Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX schließt im Plus -- US-Handel endet mit Gewinnen -- BioNTech: FDA erlaubt Auffrischungsimpfung -- Deutsche Bank erwartet Ertragsrückgang in Investmentbank -- Salesforce, HELLA, Lufthansa im Fokus

BP schließt einige Tankstellen in Großbritannien. Porsche SE beteiligt sich an israelischem Halbleiter-Spezialisten. Enger Zuckerberg-Vertrauter wird nächster Technologie-Chef bei Facebook. Boeing hebt 20-Jahres-Prognose für chinesischen Luftverkehrsmarkt leicht an. Deutsche Wohnen-Übernahme: Britischer Fonds will Vonovia Steine in den Weg legen. Volkswagen baut Batteriewerk in China.

Umfrage

Würden Sie es für richtig halten, wenn Gastronomie und Veranstaltungen nur noch Geimpften und Genesenen offen stehen?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln